a r t I C l e S During embryonic development, Notch and Wnt signaling orchestrate cell proliferation and cell fate decisions in a wide variety of tissues. The functional relationship between the two signaling pathways is intricate, and complementary or mutually exclusive activation has been reported during processes such as myogenesis, hematopoiesis and neurogenesis of the telencephalon or neural tube 1 .
Notch and Wnt signaling are also required for the development of the vertebrate neural retina. This structure develops from a neuroepithelium composed of multipotent progenitors, which go through a series of competence states to give rise to six neuronal and one glial cell types 2 . As progenitor cells produce the various cell types, Notch through lateral inhibition maintains neighboring cells in a multipotent, proliferative state, ensuring that sufficient numbers of progenitors are retained for consecutive waves of neurogenesis. Thus, downregulation of Notch is a prerequisite for retinal neuronal differentiation 2 .
Wnt-β-catenin signaling has also been implicated in the proliferation of vertebrate retinal precursors. However, in the mouse embryonic neural retina this function is limited to progenitor cells located in the periphery 3, 4 . Wnt-β-catenin signaling is not active in the central retina, and cell proliferation and differentiation proceed normally in mice with conditional deletion of β-catenin in the neural retina, although retinal lamination is altered 5 . Similarly, retina-specific inactivation of Fzd5, a noncanonical Wnt receptor, mostly influences retinal vasculature formation but has no effect on neurogenesis 6 . Although these results do not strongly implicate Wnt signaling in retinal differentiation, Sfrp1 and Sfrp2, two members of a family of postulated Wnt antagonists, are strongly expressed in the neural retina throughout neurogenesis 7 -raising the question of whether their function is related to Wnt signaling.
Sfrps (1-5 in mammals) are a family of secreted factors that fold in two independent domains. The cysteine-rich domain (CRD) at the N terminus shares similarities with the extracellular domain of the Wnt receptors Frizzled (Fzd) and ROR 8 . The C-terminal domain contains instead a netrin-related motif (NTR), which characterizes a number of unrelated proteins including Netrin-1, tissue inhibitors of metalloproteinases (TIMPs), complement proteins and type I procollagen C-proteinase enhancer proteins (PCOLCEs) 8 . Owing to their homology to the extracellular portion of Fzd receptors, Sfrps were first described and generally accepted as Wnt antagonists that bind and sequester Wnt ligands, thereby preventing signal activation. Gain of Sfrp1 or Sfrp2 function has supported this idea, as excess Sfrp function antagonizes Wnt signaling in a variety of contexts 8 . Loss of Sfrp function instead points to two additional important features. First, Sfrp function might be redundant, because genetic inactivation of individual family members in mice seems to have little effect on embryonic development 9, 10 . Double inactivation of Sfrp1 and Sfrp2, by contrast, causes a variety of alterations 9, 11, 12 , some of which are worsened by the additional inactivation of Sfrp5 (refs. 9,11) . Second, Sfrps have Wnt-independent functions 9, 12 , as Sfrp-null phenotypes are only partially explained by overactivation of Wnt-β-catenin signaling 11 or alterations in the noncanonical Wnt-PCP (planar cell a r t I C l e S polarity) pathway. Consistent with this notion, several studies have implicated individual Sfrps in the Wnt-independent regulation of other cell signaling mechanisms. For example, Sfrp1 can interact with and inhibit the activity of RANKL, a member of the tumor necrosis factor (TNF) family that is involved in osteoclast formation 8 . Sfrp2 specifically binds to tolloid metalloproteinases and thereby regulates procollagen processing during myocardium infarction 13, 14 . Sfrp2 also interacts with an integrin-fibronectin complex that modulates apoptosis 8 . Furthermore, Sizzled (a member of the family that is not present in mammals) acts as a negative feedback regulator of bone morphogenetic protein (BMP) signaling by binding to BMP1-Tolloid, a metalloprotease that normally degrades the BMP antagonist chordin 15, 16 .
By analyzing the functional consequences of compound inactivation of Sfrp1 and Sfrp2 during mouse retinal neurogenesis, we found that Sfrps have a Wnt-independent role in the regulation of Notch signaling. We explain this finding by demonstrating that Sfrps can bind to and downregulate the activity of ADAM10, a metalloprotease with multiple substrates, including Notch, N-cadherin and amyloid precursor protein (APP).
RESULTS

Sfrp1 and Sfrp2 are essential for proper eye development
Sfrp1 and Sfrp2 are expressed during murine eye development with a complementary pattern that includes all eye structures 7 . Sfrp1 transcripts are localized to the optic cup periphery and the retina pigmented epithelium from embryonic day 10.5 (E10.5), whereas Sfrp2 is predominant in the neural retina (Supplementary Fig. 1 ).
Despite restricted mRNA expression, Sfrp proteins efficiently diffuse in the extracellular space 17 and Sfrp1 was also immunodetected, albeit at low levels, in the neural retina ( Supplementary Fig. 1 ), supporting the proposed functional redundancy of Sfrps 9, 11, 12 . Accordingly, the eyes of Sfrp1 or Sfrp2 singlenull embryos appeared histologically normal. By contrast at E16.5, the latest viable stage, the eyes of Sfrp1 −/− ; Sfrp2 −/− compound mutants (n = 20) were smaller than those of control littermates (n = 30) with visible morphological alterations, including dorsal peripheral defects, reduction in lens size, abnormal cornea and eye lid formation, increased thickness of the neural retina and abnormal vitreal accumulation of mesenchyme-derived angioblasts that normally form the hyaloid artery, the major vascular structure of the embryonic eye (Supplementary Fig. 2 ).
Inactivation of Sfrp1 and Sfrp2 alters retinal neurogenesis Multipotent progenitors in the neural retina generate neurons and one type of glia with an established temporal order. The first cells to be generated are retinal ganglion cells (RGCs), followed by amacrine and cone photoreceptors, and bipolar neurons and Müller glial cells are the last 2 . Although Wnt signaling does not seem to participate in retinal neurogenesis 4, 5 , the neural retina of Sfrp1 −/− ; Sfrp2 −/− embryos was abnormally thick and had vascular defects, as shown by immunohistochemistry with endothelial and pericyte-specific markers (Supplementary Fig. 2 ). At E16.5, the number of Islet1 + , Pax6 + RGCs, Islet1 + and Pax6 + amacrine cells and Otx2 + early-born photoreceptors (74 ± 5.72 versus 52 ± 3.70 in controls) was greater in the neural retina of Sfrp1 −/− ; Sfrp2 −/− embryos than in wild-type embryos, whereas PKCα + bipolar progenitors were virtually absent (2.33 ± 0.408 versus 29 ± 3.417 in controls) (Fig. 1a-h ).
This increased differentiation of Sfrp1 −/− ; Sfrp2 −/− retinas was not due to a premature onset of cell differentiation because we found no Tuj1 + differentiating neurons in either control or mutant retinas at E10.5 (data not shown). However, half a day later Tuj + and Islet1/2 + RGCs in mutant retinas clearly outnumbered those in control retinas ( Fig. 1i-l) . This difference was associated with a marked increase in and BrdU (proliferating precursors) and counterstained with DAPI (blue; a-h and k,l). RGCs and amacrine cells are increased, whereas bipolar cells are decreased in the mutant retinas. Proliferation in the mutant retinas is increased at early stages but is reduced at E16.5 as compared to controls (compare r to q). (s) Quantification of BrdU + , Islet1 + , Otx2 + and PKC + cells. Positive cells were counted in equivalent areas of the central retina. Error bars are s.e.m. of at least three sections from four different embryos (n = 4). cNR, central neural retina; le, lens; RPE, retina pigmented epithelium. *P < 0.05; **P < 0.01; ***P < 0.001. Scale bar, 30 µm (a-l,q,r); 60 µm (o,p); 100 µm (m,n). a r t I C l e S BrdU + proliferating cells, which was already evident in the neural retinas of E10.5 Sfrp1 −/− ; Sfrp2 −/− embryos when compared to control littermates (Fig. 1m,n) . Furthermore, analysis of the distribution of E10.5 Sfrp1 −/− ; Sfrp2 −/− retinal cells during the cell cycle using flow cytometry-based DNA content analysis revealed an increased distribution in the G2/M phase (G 1 , 55%; S, 29.3%; G 2 , 6.58%) when compared to that of control littermates (G 1 , 51.8%; S, 30.4%; G 2 , 3.08%). This increase was only transient because at E16.5 the number of BrdUpositive cells was significantly reduced in the Sfrp1 −/− ; Sfrp2 −/− retinas as compared with controls (P = 0.006; Fig. 1q-s) . Thus, inactivation of Sfrp1 and 2 seemed to force the generation of progenitor cells and their differentiation into early born neurons, possibly depleting the proliferating progenitor pool and consequently reducing late-born cell types.
Sfrp1 and Sfrp2 inhibit Notch signaling
The number of progenitor cells available for neural differentiation at any given time is controlled by Notch signaling 2 . To search for a Wnt-independent mechanism that could explain the neural retina phenotype of Sfrp mutants, we tested whether the Notch pathway was normally activated. Upon ligand binding, the Notch receptor becomes susceptible to two sequential proteolytic cleavages that enable the release of an active intracellular form of Notch (NICD). NICD translocates to the nucleus where it interacts with the CSL transcription factor and recruits coactivators to turn on the expression of Notch target genes, such as Hes5 (ref. 18 ). Nuclear localization of NICD is then a reliable determinant of Notch signaling activation 18 .
In E12.5 control retinas, the number of NICD + progenitor cells that were available for neural differentiation occupied only a reduced central region 19 (Fig. 2a) whereas in the Sfrp1 and 2 mutants a substantially larger number of NICD + cells were distributed in most of the neural retina (Fig. 2b) . With time, this difference became progressively inverted: at E13.5 the number of NICD + cells was similar in control and mutant retinas but by E16.5 mutant retinas tended to contain fewer NICD + cells than control retinas (Fig. 2c-f ,k). Consistent with broad activation of the Notch pathway, the distribution of Hes5 was similarly expanded in the Sfrp1 −/− ; Sfrp2 −/− retinas (Fig. 2g,h ), whereas that of the Notch ligand Delta-like1 (Dll-1), which is repressed upon activation of Notch signaling 18 were abnormally low in the mutant neural retina (Fig. 2i,j) . Quantitative RT-PCR analysis of Hes5 (0.90 ± 0.11 in mutants versus 0.41 ± 0.007 in controls; n = 3, P < 0.05) and Dll-1 (0.602 ± 0.052 in mutants versus 0.81 ± 0.048 in controls; n = 3, P < 0.05) mRNA levels from E12.5 and E13.5 control and Sfrp knockout retinas confirmed these variations. Together these data indicated that, in the absence of Sfrp1 and 2, Notch signaling was abnormally active in a larger number of retinal progenitors; this explains the early increase in cell proliferation. In turn, this simultaneous activation suppressed ligand expression, prematurely terminated proliferation of retinal progenitors and favored their differentiation, explaining the accumulation of early-differentiating neurons in Sfrp-null retinas.
We reasoned that if Sfrps directly or indirectly downregulate Notch activity, similar alterations should occur in other brain regions where Notch and Sfrp1 and 2 are coexpressed, such as the telencephalon 20, 21 . Indeed, western blot analysis of E12.5 Sfrp1 −/− ; Sfrp2 −/− and control cortex revealed that Notch was expressed at similar levels in both extracts but that NICD expression was fourfold higher in the mutants (Fig. 2l) . This increase was paralleled by defects in telencephalic neurogenesis similar to those observed in the retina (I.C., P.B. and P.E., unpublished observations).
ADAM10 inhibition rescues the Sfrp mutant retinal phenotype
The disintegrin and metalloprotease transmembrane protein ADAM10 is responsible for the first proteolytic cleavage of the Notch receptor on ligand binding 22, 23 . ADAM10-mediated shedding of the Notch ectodomain is a limiting step for the subsequent proteolysis by the γ-secretase-presenilin complex, which releases the NICD. ADAM10 is inhibited by TIMPs 24 through the activity of their NTR modules 24, 25 . Because Sfrp1 and 2 contain NTR modules 8 , we postulated that they might normally downregulate the activity of ADAM10. If this were the case, inhibition of ADAM10 activity should counteract the impaired neurogenesis observed in the Sfrp1 −/− ; Sfrp2 −/− neural retina.
G1254023X is a synthetic compound that inhibits ADAM10 with high affinity 26 . We investigated its effect on retinal neurogenesis using organotypic optic cup cultures from E11. Fig. 3 ). Addition of G1254023X to the culture medium of control retinas reduced the rate of cell proliferation when compared to vehicle treatment ( Supplementary Fig. 3 ). Exposure of Sfrp1 −/− ;Sfrp2 −/− optic cups to low concentrations of G1254023X was sufficient to reduce the number of BrdU + cells to values statistically undistinguishable from those of controls (Fig. 3a,c,i) . However, increasing G1254023X concentrations (5 µM) further reduced the number of BrdU + cells in Sfrp1 −/− ; Sfrp2 −/− retinas to values below those of control retinas, supporting the idea that normally Sfrp1 and Sfrp2 negatively modulate, but do not completely block, Notch processing. Notably, G1254023X did not significantly change the number of Islet1 + cells in the Sfrp1 −/− Sfrp2 −/− optic cup cultures at low doses (P = 0.279), but at higher concentrations favored cell differentiation (Fig. 3e-h,j) . Probably, downregulation of ADAM10 at a time when a substantial amount of early-born neurons has been already generated (Fig. 1l,s) is not sufficient to restrain cell cycle exit in the mutants. Rather, further inhibition of Notch activation promotes neuronal differentiation, as reported in the retina 2 .
Sfrps interfere with the proteolysis of ADAM10 substrates Together, the above findings supported the possibility that the Sfrp1 −/− ; Sfrp2 −/− retinal phenotype could be at least in part explained by uncontrolled activity of ADAM10. We next postulated that, if this was the case, the processing of physiological ADAM10 substrates other than Notch should be equally altered in Sfrp null retinas. ADAM10 sheds the extracellular domain of N-cadherin and L1-CAM, two cell adhesion molecules that are abundantly expressed in embryonic retinas. This proteolytic cleavage produces fragments of 40 kDa and 32 kDa, respectively, and is a prerequisite for further proteolysis by a γ-secretase, which generates intracellular peptides of 35 kDa for N-cadherin 27 and 28 kDa for L1-CAM 28 . Western blot analysis of extracts from E13 and E16.5 Sfrp1 −/− ; Sfrp2 −/− and control retinas showed that the amount of L1-CAM 32 kDa and N-cadherin 35 kDa peptides were almost doubled in the mutants (70% and 68% of control values, respectively), although both proteins were expressed at similar levels in both genotypes (Fig. 4a,b) . Consistent with the latter observation, membrane-bound active β-catenin, which requires intact N-cadherin to tether the membrane 27 , was almost undetectable in the mutant retinas (Fig. 4c,d) .
In addition to neural development, ADAM10 is crucial for tissue homeostasis. Most notably, ADAM10 is responsible for the nonamyloidogenic processing of APP, a key protein in the onset of Alzheimer's a r t I C l e S disease. ADAM10-mediated processing of APP cleaves the protein within the βamyloid peptide, preventing its toxic generation and promoting the shedding of a large soluble APP ectodomain 29 (sAPPα). APP is poorly expressed in the developing retina (not shown) but its intact and sAPP forms are abundant in the subventricular zone of the lateral ventricle in adult mice 30 . If Sfrp1 normally antagonizes the α-secretase activity of ADAM10, sAPPα should be enriched in the lateral ventricle of adult Sfrp1 −/− mice. Comparative western blot analysis of isolated lateral ventricle regions from Sfrp1 −/− and wild-type brains confirmed an eightfold increase in sAPP in the mutants (Fig. 5a) . sAPPα is constitutively released from the surface of most cultured cells. Consistently, the amount of sAPPα recovered from CHO cells stably transfected with Sfrp1, but not Sfrp2, was substantially reduced (47%) compared to control, mock-transfected CHO cells, although APP was expressed at similar levels in all the cell lines (Fig. 5b) . Similarly, the addition of soluble recombinant Sfrp1, but not Sfrp2, substantially reduced (35%) the levels of sAPPα recovered from the medium of CHO cells (Fig. 5c) , further demonstrating that Sfrp1 is a specific inhibitor of ADAM10-mediated APP processing. The difference between Sfrp1 and Sfrp2 on APP processing raises the possibility that the inhibitory specificity of Sfrps may be influenced by the nature of the substrate, as shown for other TIMPs 31 .
Together, these data indicate that Sfrp1, and probably Sfrp2, act as ADAM10-specific TIMPS.
Sfrp1 and ADAM10 physically interact
TIMPs usually exert their action by binding to their target metalloproteases 31 . To test whether Sfrps acted with a similar mechanism, we investigated whether Sfrp1 and ADAM10 physically interact. To this end we attempted to coimmunoprecipitate Sfrp1 and ADAM10 from embryonic retinal tissue and cortical tissue, in which Sfrp1 is more abundantly expressed.
Sfrp1-specific antibodies immunoprecipitated ADAM10 from wildtype but not from Sfrp1 −/− ; Sfrp2 −/− tissues (Fig. 6a) . Unfortunately, we found that ADAM10 antibodies were not efficient in reverse immunoprecipitation experiments. To circumvent this problem, we cotransfected Sfrp1-HA and ADAM10-myc constructs in 293T cells and analyzed the derived cell lysates to demonstrate that antibodies to myc specifically coimmunoprecipitated Sfrp1-HA with ADAM10 (Fig. 6b) . Furthermore, secreted AP-tagged Sfrp1 seemed to bind more abundantly on ADAM10-overexpressing CHO cells than on mock-transfected cells, which constitutively express low ADAM10 levels 31 (Fig. 6c-f) .
Sfrp1 targets ADAM10 function independently of Wnt
The above findings support the idea that Sfrps can bind ADAM10 and directly modulate its function. However, the partial rescue of the To this end we turned to the Drosophila wing imaginal disc, the development of which is regulated by both Wnt and Notch signaling. In contrast to the vertebrate retina, the interactions between these two pathways and their direct and specific downstream targets have been unequivocally identified in Drosophila 32 . Drosophila offers also a natural Sfrp-null background because no apparent Sfrp homolog has been identified in its genome 8 . Nevertheless, wingless efficiently binds to Sfrp1 (ref. 33 ) mimicking the vertebrate Wnt1 or Wnt8 interaction 34 .
Taking advantage of this interaction, we have shown that HhGal4>UAS-Sfrp1 ectopic expression of Sfrp1 in the posterior compartment of the Drosophila wing imaginal disc interferes with the symmetrical gradient of wingless at the dorsoventral boundary of the wing imaginal disc (Fig. 7) . It thereby prevents, in the posterior but not in the anterior compartment that serves as control, the expression of Senseless (Sens), a canonical target normally activated by high wingless levels in two discrete and symmetrical stripes at the dorsoventral compartment boundary 35 (P.E., A. Sandonis, C.I., A. Shimono, I.G. and P.B., unpublished observations) (Fig. 7a,b) . We thus tested whether Sfrp1 could similarly interfere with the expression of genes that are directly activated by Notch signaling. Cut, one such target, is symmetrically expressed in the stripes of Sens at the dorsoventral compartment boundary 32 . In the HhGal4>UAS-Sfrp1 wing discs, Cut expression was totally abolished in the posterior but not the anterior compartment (Fig. 7c) , supporting the idea that Sfrp1 interferes with Notch signaling. Consistently, the wings of adult UAS-myc-Sfrp1>Hh-Gal4 flies had notches in the posterior wing margin, a phenotype characteristic of alterations in the wingless and Notch pathways (Fig. 7e,f) . Most notably, forced expression of Kuzbanian (Kuz; the Drosophila ADAM10 homolog) together with Sfrp1 in the posterior compartment completely rescued Cut expression, whereas it had no effect on expression of the wingless target Sens (Fig. 7d) . Together these results strongly support the idea that Sfrp1 targets ADAM10 (Kuz) function, thereby interfering with Notch signaling independently of Wnt.
DISCUSSION
The onset and progression of neurogenesis in the vertebrate retina is regulated by interactions among the fibroblast growth factor, sonic hedgehog (Shh), Wnt and Notch signaling pathways. Comparison of the mechanisms that operate in different species offers two key observations. First, there are species-specific differences in the precise composition and onset of each pathway, which reflect individual retinal characteristics 36 . Second, individual elements of one pathway respond or are used in other signaling cascades or cellular activities. For example, in the eye, Hes1, an established Notch target, is also independently regulated by Shh and Wnt signaling 37, 38 , and β-catenin, a key element of Wnt signaling, has a well characterized function in cell-cell adhesion 5 . We have shown that Sfrps, which modulate Wnt signaling, act as negative regulators of Notch. This Sfrp function provides an additional example of how individual molecules are shared by different signaling cascades. Mechanistically, Sfrps bind and, independently of Wnt, downregulate the α-secretase activity of ADAM10, which is responsible for the proteolytic cleavage of the Notch receptor and thus for subsequent pathway activation 23 . Furthermore, by targeting ADAM10, Sfrps regulate the proteolysis of other specific substrates, including N-cadherin, L1-CAM and APP.
These conclusions stem from the initial observation that in Sfrp1 −/− ; Sfrp2 −/− embryos the periphery of the optic cup is not specified and the neural retina is abnormally thick. Specification of the optic cup periphery depends on Wnt signaling activation 3, 4 . Sfrp1 and 2 are required to activate canonical signaling in the periphery of the optic cup, probably by promoting the diffusion of Wnt ligands (P.E., A. Sandonis, C.I., A. Shimono, I.G. and P.B., unpublished observations). However, this mechanism could not explain the transient increase in proliferation and enhanced generation of early born neurons in the Sfrp1 −/− ; Sfrp2 −/− neural retina, because previous studies had shown that Wnt signaling is not important for retinal neurogenesis in mice 5, 6 . We also considered it unlikely that the retinal phenotype could be secondary to the vascular defects observed in Sfrp1-and 2-null mice, because neurogenesis proceeds normally in embryos in which the hyaloid artery does not form 39 . Instead, we showed that abnormal retinal neurogenesis could be explained by a transient increase in Notch signaling, probably caused by enhanced ADAM10 activity. In support of this interpretation, pharmacological inhibition of ADAM10 rescued the enhanced cell proliferation of Sfrp1 −/− ; Sfrp2 −/− neural retinas. Furthermore, conditional inactivation of Adam10 in neural progenitor cells causes depletion of early a r t I C l e S progenitors and a reduction in α-secretase-mediated processing of APP 22 , a phenotype opposite to that observed in Sfrp1 −/− ; Sfrp2 −/− retinas or in the cortex of Sfrp1 −/− embryos (I.C., P.B. and P.E., unpublished observations), where Notch and APP processing are upregulated. Similar defects also characterize the cortex of embryos that lack RECK (reversion-inducing cysteine-rich protein with Kazal motifs), a membrane protein that is localized to cortical precursor cells and is thought to inhibit ADAM10 sheddase activity but using Notch ligands as substrates 40 .
Our analysis of the Sfrp-null ocular phenotype together with overexpression studies in the Drosophila wing disc support the idea that Sfrps independently modulate Wnt and Notch. Sfrp1 in the posterior compartment of the Drosophila wing imaginal disc interferes with the expression of Wnt and Notch target genes but coexpression of Sfrp1 and ADAM10 (Kuz) completely rescue the expression of Notch targets but not of wingless targets. Therefore, when coactivated, these pathways may compete for Sfrp-mediated regulation, providing an additional frame in which to interpret the reported functional interaction between Wnt-canonical and Notch signaling in several contexts 41 .
The ADAM family of metalloproteases is large. Phylogenetic and functional analysis of the human members indicates that ADAM10 is closely related to ADAM17 but that they are separated by other family members. The distributions of Adam10 and Adam17 largely overlap and initial studies suggested that both metalloproteases participated in Notch and APP cleavage 29, 42 . Therefore, we cannot exclude the possibility that abnormal activity of ADAM17 might contribute to the ocular phenotype of Sfrp1 −/− ; Sfrp2 −/− mice. The existence of Sfrp-mediated regulation of ADAM17 might, for example, help to explain why specific pharmacological inhibition of ADAM10 only partially rescued the retinal phenotype of Sfrp1 −/− ; Sfrp2 −/− embryos. However, we favor the hypothesis that, at least in the CNS, Sfrp1 and 2 largely target ADAM10 function. Indeed, genetic inactivation in mice indicates that Adam10 has a preponderant function in the developing CNS and cardiovascular system, whereas Adam17 regulates epithelial maturation of multiple organs 42 . Furthermore, recent studies have shown that at least in the CNS Notch, APP and N-cadherin are ADAM10-specific substrates 22, 43 . In line with these findings, we have shown that the proteolytic processing of these three substrates, as well as that of L1-CAM, was altered in Sfrp1 −/− ; Sfrp2 −/− mice. Nevertheless, future studies in other tissues, where ADAM17 appears to be preponderant, should help to resolve the specificity of Sfrps on ADAM regulation.
Sfrp2 and Sizzled, a nonmammalian Sfrp family member, have been shown to regulate Tolloid metalloproteinases (also known as procollagen C-proteinases), but with different functions. In vertebrates, BMP activity is in part controlled by the BMP antagonist Chordin which, in turn, is inactivated through cleavage by Tolloid. Sizzled, but apparently not Sfrp2 (ref. 13 ), binds to Tolloid and behaves as a TIMP to competitively inhibit its enzymatic activity, thereby preventing Chordin cleavage 15, 16 . Sfrp2 instead interacts through its CRD with the nonprotease domain of Tolloid proteases and enhances or inhibits their procollagen-C proteinase activity 13 depending on its concentration 14 . The way in which Sfrp1, and possibly Sfrp2, inhibits ADAM10 is unclear but might be similar to the above mechanisms.
Sfrps, TIMPs and PCOLCEs share similarities in the NTR domain; in TIMPs and POLCEs, this domain is thought to interfere with protease activity 44 . The structure of ADAM10 comprises, adjacent to the catalytic and disintegrin domains, a cysteine-rich motif that is thought to mediate interactions with other molecules 42 . In a plausible model ( Supplementary Fig. 4) , binding of the respective cysteinerich motifs may be responsible for Sfrp-ADAM interactions, which would bring the Sfrp NTR domain close to the ADAM10 catalytic site. Thus, Sfrp1 or 2 would interfere with the enzymatic activity of ADAM10 by competing for substrate binding. Given the molecular diversity of metalloprotease substrates, it is possible that the inhibitory specificity may be in part linked to the nature of the substrates, as suggested by the specific effect of Sfrp1 but not Sfrp2 on APP processing. This possibility is supported by tissue distribution. In fact, APP and Sfrp1, but not Sfrp2, are particularly abundant in the telencephalon. By contrast, ADAM10-mediated processing of Notch in the retina seems to involve both Sfrp1 and Sfrp2.
Independently of the precise mechanism of action, the dual role of Sfrps in the regulation of Wnt signaling and ADAM10 activity might be relevant in different pathological situations, especially in neurodegenerative diseases or metastatic events, where both Wnt signaling components and metalloproteases have key roles 41 . For example, ADAM10 confers metastatic capacity on colorectal cancer 45 . Loss of SFRP1 and SFRP2 expression due to promoter hypermethylation occurs frequently in proliferating and invasive tumors 8 . Conversely, ectopic Sfrp1 expression inhibits tumor growth and lung metastasis induced by inoculation of an invasive tumorigenic cell line 46 , notably associated with changes in both Wnt-β-catenin and extracellular matrix components 46 . Thus, potentiation of Sfrp1 activity might control both Wnt-mediated tumor proliferation and ADAM-mediated invasion.
On the contrary, our results point to the inhibition of Sfrp1 as a potential mechanism for preventing the toxic accumulation of Aβ peptides, one of the landmarks of Alzheimer disease. Indeed, in the absence of Sfrp1 function, APP processing should shift toward the production of sAPPα, thus preventing the generation of Aβ, as recently shown for SIRT1, a deacetylase that directly activates the transcription of ADAM10 (ref. 47) . Whether this would be beneficial in patients with Alzheimer's disease is worth testing, although it is becoming apparent that the contribution of APP proteolytic derivatives to the pathology of Alzheimer's disease is more complex than was originally envisaged.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
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